Cannabinoid Receptor
Cannabinoid receptors are GPCRs that mediate the effects of endogenous cannabinoids (endocannabinoids) and phytocannabinoids, such as those found in cannabis. The two main types of cannabinoid receptors, CB1 and CB2, are involved in regulating a wide range of physiological processes, including pain perception, appetite, mood, and immune function. Cannabinoid receptor modulators have therapeutic potential in treating conditions such as chronic pain, epilepsy, and multiple sclerosis. At CymitQuimica, we offer a wide range of high-quality cannabinoid receptor modulators to support your research in neuropharmacology, pain management, and immunology.
Found 226 products for "Cannabinoid Receptor".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Hemopressin(human, mouse) TFA
CAS:Hemopressin TFA: nonapeptide from hemoglobin, oral CB1 inverse agonist, eases inflammatory pain.Formula:C52H80F3N13O14Purity:98%Color and Shape:SolidMolecular weight:1168.27UVI3502
UVI3502 is a cannabinoid receptor 1 (CB1) antagonist with an IC50 value of 4641 nM for CB1 and approximately 16200 nM for CB2. It can inhibit Gi/o protein coupling induced by the agonist CP55,940. UVI3502 shows potential for research into diseases related to the endocannabinoid system in the central nervous system, such as cognitive impairments and neurodegenerative disorders.SCOTfluor-89
CAS:SCOTfluor-89 is a small, conjugatable, orthogonal, and multicolor fluorescent group designed for in vivo imaging of cell metabolism.Formula:C12H14N4O7SeColor and Shape:SolidMolecular weight:405.22CB1-IN-3
CB1-IN-3 (Compound 6i) is a potent inhibitor of the cannabinoid receptor type 1 (CB1). It holds potential for research in obesity, inflammation, and neurological disorders.Color and Shape:Odour SolidCB2 receptor antagonist 2
Compound 39, also known as CB2 receptor antagonist 2, is a potent CB2 antagonist exhibiting an IC50 of 0.33 μM.Color and Shape:Odour SolidN-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide
CAS:N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide: binds CB1 (Ki=365 nM), activates PPARα (EC50=698 nM), reduces rat food intake, no FAAH inhibition.Formula:C27H45NO3Color and Shape:SolidMolecular weight:431.661Hemopressin (human, mouse)
CAS:Endogenous peptide, inhibits ep24.15/24.16/ACE with Ki of 27.76/3.43/1.87 μM. Lowers blood pressure, CB1 inverse agonist, reduces pain in vivo.Formula:C50H79N13O12Purity:98%Color and Shape:SolidMolecular weight:1054.26Tocrifluor T1117
CAS:Fluorescent form of AM 251, CB1 receptor antagonistFormula:C56H53Cl2N7O5Purity:98%Color and Shape:SolidMolecular weight:974.97TRPV1/CB2 agonist 1
TRPV1/CB2 agonist 1 (compound 41) is a dual agonist targeting hTRPV1 and CB2 receptors, with an EC50 value of 26.8 μM for hTRPV1. It is applicable in research related to the nervous system.Color and Shape:Odour SolidVicasinabin
CAS:Vicasinabin: potent CB2 agonist; researches chronic pain, atherosclerosis, bone mass, neuroinflammation.Formula:C15H22N10OColor and Shape:SolidMolecular weight:358.41CB1R antagonist 2
CB1R antagonist 2 (Compound 11g) functions as an antagonist of the cannabinoid receptor 1 (CB1R), inhibiting the MAPK/NF-κB signaling pathway and exhibiting anti-inflammatory properties. In RAW264.7 cells, it suppresses LPS-induced expression of IL-6, IL-1β, and TNF-α. In murine models, it improves OVA-induced allergic rhinitis.Formula:C24H26N4OColor and Shape:SolidMolecular weight:386.49Calcitonin-13C6,15N4 trifluoroacetic acid
Calcitonin-13C6,15N4 trifluoroacetic acid is a version of calcitonin (salmon) labeled with carbon-13 and nitrogen-15. This hormone regulates calcium and acts dualistically as an agonist to both amylin and calcitonin receptors, promoting bone formation while inhibiting bone resorption.Formula:C1401C5H240N4315NO48S2·5C2HF3O2Color and Shape:SolidMolecular weight:4007.93Drinabant
CAS:Drinabant (AVE-1625) is an orally active CB1 receptor antagonist.Formula:C23H20Cl2F2N2O2SPurity:99.92%Color and Shape:SolidMolecular weight:497.38CB2R/FAAH modulator-2
CAS:CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH.Formula:C24H33NO2Purity:99.15%Color and Shape:SolidMolecular weight:367.52Zevaquenabant
CAS:Zevaquenabant (S-MRI-1867): oral CB1/iNOS antagonist combatting obesity-induced CKD.Formula:C25H21ClF3N5O2SColor and Shape:SolidMolecular weight:547.98Cannabicitran
CAS:Cannabicitran is a cannabinoid that can decrease rabbits intraocular pressure [1] [2].Formula:C21H30O2Color and Shape:SolidMolecular weight:314.46(R)-Zevaquenabant
(R)-Zevaquenabant ((R)-MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS). It is beneficial in improving chronic kidney disease (CKD) caused by obesity.Color and Shape:Odour SolidRVD-Hpα
CAS:N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist.Formula:C65H105N19O17Purity:98%Color and Shape:SolidMolecular weight:1424.66TRPM8 antagonist 4 prodrug
TRPM8 antagonist 4 prodrug (Compound 8b) is an orally active CB2R agonist (EC50: 51.2 nM) and a weak TRPM8 antagonist. It acts as a prodrug of TRPM8 antagonist 4, exhibiting anti-inflammatory and analgesic properties. TRPM8 antagonist 4 prodrug is applicable in studies of inflammation-related pain disorders.Δ8-THC-C8
CAS:Δ8-THC-C8 is a semi-synthetic cannabinoid. It acts as an agonist for the cannabinoid receptor 1 (CB1) with an EC50 value of 13.8 nM.Formula:C24H36O2Color and Shape:SolidMolecular weight:356.54
